时　间：2009年9月16日(周三)下午3：30

　　 September 16th, 2009(Wednesday), 3:30PM

　　地　点：北京大学医学部逸夫教学楼114室

　　 RM 114, Yifu Building, Peking University Health Science Center

题  目：日本临床研究的现状和今后的方向

　　 Research in Japan: present status and future directions

报告人：佐藤裕史教授MD PhD

　　庆应义塾大学医学部 临床研究中心

Professor Yuji Sato MD PhD

Centre for Clinical Research, Keio University School of Medicine

 欢迎参加！记学分！

北京大学临床研究所

2009年9月2日

　　报告人简介：

　　Professor Yuji Sato got his doctor degree of Medicine in March 1989, and got his PhD in psychopharmacology in March 1996, Now he is a pharmaceutical medicine specialist and he works in the Centre for Clinical Research, Keio University School of Medicine. His Specialty include Clinical pharmacokinetics, Pharmaceutical Medicine, Adolescent psychiatry, Dynamic psychotherapy, Psychopathology. He is the Vice Chairperson of Japan Association of Pharmaceutical Medicine and the member of Japanese Society of Psychiatry and Neurology, Japanese Society of Neuropsychology, Japanese Society for Higher Brain Dysfunction and Japanese Center of Pharmaceutical Medicine.

报告摘要：

There are some issues in the development of clinical research in Japan, for example :

l         Relatively low output in view of global standard comparison with its basic research

l         Clinical trials lagging behind evolving clinical research and development outside Japan

l         Current standards for clinical trials require a myriad of experts from different specialties. This infrastructure has not been ideal in Japan

　　Improvement of infrastructure is a sine qua non for high-standard clinical research, which is essential to translate outstanding basic and clinical innovation into globally-acceptable evidence. Besides, emerging Asian countries with appropriate infrastructure to conduct multinational trials implies lesser incentives for industries to sponsor trials in Japan; hence so-called hollowed clinical research in Japan being a buzzword.  It is of utmost importance to urgently tackle these issues in order to fill in the existing gaps and lags so that no more opportunities are to be lost.